Dalia Moawad

Dalia Moawad, MD has a diverse and extensive background in medical affairs, clinical research, and health informatics. With experience in various pharmaceutical companies such as Genentech, Five Prime Therapeutics, Bristol-Myers Squibb, and Affymax, Dalia has held leadership roles in neuro rare diseases, influenza, and established products. Dalia has also been involved in clinical trials and projects related to hepatitis, liver transplant, and telemedicine. With a strong educational foundation in medicine and surgery from Ain Shams University, Dalia brings a wealth of expertise to their work in the medical field.